Boulder, Colorado
United States
17
2025-07-31
The entities that hold a legal rights for patent applications filed by inventor Garcea Robert:
Robert Garcea from Boulder, US has applied for patents for these inventions. The list has both pending applications and granted patents:
COMPOSITIONS AND METHODS FOR MAKING AND USING THERMOSTABLE IMMUNOGENIC FORMULATIONS WITH INCREASED COMPATIBILITY OF USE AS VACCINES AGAINST ONE OR MORE PATHOGENS
#2 | 2024-07-25COMPOSITIONS AND METHODS FOR REDUCING ADVERSE EFFECTS OF STORAGE, TRANSPORT AND ADMINISTRATION OF ANTIGEN-CONTAINING FORMULATIONS
#3 | 2024-07-11COMPOSITIONS, METHODS AND USES FOR THERMALLY STABLE MULTI-TARGETED ANTIGENS
#4 | 2024-04-25Compositions, methods and uses for thermally stable multi-targeted antigens
#5 | 2023-11-09COMPOSITIONS, METHODS AND USES FOR THERMALLY STABLE HUMAN PAPILLOMAVIRUS FORMULATIONS
#6 | 2023-09-21COMPOSITIONS, METHODS AND USES FOR THERMALLY STABLE HUMAN PAPILLOMAVIRUS FORMULATIONS
#7 | 2022-11-24COMPOSITIONS, METHODS AND USES FOR THERMALLY STABLE HUMAN PAPILLOMAVIRUS FORMULATIONS
#8 | 2022-08-25Compositions and methods for making and using thermostable immunogenic formulations with increased compatibility of use as vaccines against one or more pathogens
#9 | 2022-06-09Compositions, methods and uses for thermally stable multi-targeted antigens
#10 | 2022-05-12COMPOSITIONS, METHODS AND USES FOR THERMALLY STABLE HUMAN PAPILLOMAVIRUS FORMULATIONS
#11 | 2021-03-18COMPOSITIONS, METHODS AND USES FOR THERMALLY STABLE HUMAN PAPILLOMAVIRUS FORMULATIONS
#12 | 2020-12-10Compositions and methods for making and using thermostable immunogenic formulations with increased compatibility of use as vaccines against one or more pathogens
#13 | 2019-06-20COMPOSITIONS, METHODS AND USES FOR THERMALLY STABLE HUMAN PAPILLOMAVIRUS FORMULATIONS
#14 | 2019-05-09Compositions, methods and uses for thermally stable multi-targeted antigens
#15 | 2019-02-14Compositions and methods for making and using thermostable immunogenic formulations with increased compatibility of use as vaccines against one or more pathogens
#16 | 2017-03-09COMPOSITIONS, METHODS AND USES FOR THERMALLY STABLE HUMAN PAPILLOMAVIRUS FORMULATIONS
#17 | 2007-09-13Stable (fixed) forms of viral capsid proteins, and viral capsid protein fusions, preferably papillomavirus L1 proteins, and uses thereof
1816514 ⎘